Incyte INCY
$114.63 −$1.25 (-1.07%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $114.63 0.00%
Open$116.85
Prev close$115.87
Day range$114.28 – $117.51
Volume1.54M
Market cap$23.36B
P/E (TTM)58.5
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.56B+14.0% YoY
Operating profit-$707.45M-264.0% YoY
Net profit-$784.80M-285.0% YoY
Diluted EPS-$3.86-282.9% YoY
Free cash flow-$690.95M-233.0% YoY
Operating cash flow-$675.32M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin92.7%
Operating margin11.7%
Net margin6.7%
Return on equity7.8%
Return on assets5.9%
Return on invested capital6.2%
Current ratio3.84
Liabilities / assets22.6%
Cash & investments$3.85B
Total debt$27.63M
Net cash (debt)$3.83B
Free cash flow / sales11.3%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.56B | $1.67B | $1.27B | $5.14B | $1.51B |
| Total Operating Revenue | $1.56B | $1.67B | $1.27B | $5.14B | $1.51B |
| Cost of Revenue | $108.70M | $105.00M | $104.50M | $372.10M | $121.10M |
| Gross Profit | $1.45B | $1.57B | $1.17B | $4.77B | $1.39B |
| Operating Expense | $2.16B | $868.65M | $844.00M | $3.43B | $1.00B |
| Selling and Admin Expenses | $364.30M | $351.70M | $328.10M | $1.38B | $390.40M |
| -General & Admin Expense | $364.30M | $351.70M | $328.10M | $1.38B | $390.40M |
| Research & Development | $1.79B | $516.95M | $515.90M | $2.05B | $611.37M |
| Operating Profit | -$707.45M | $700.39M | $324.17M | $1.34B | $383.96M |
| Net Non-Operating Interest Income (Expense) | $31.57M | $37.54M | $33.12M | $103.17M | $30.17M |
| Non-Operating Interest Income | $32.17M | $38.12M | $33.69M | $105.60M | $30.75M |
| Non-Operating Interest Expense | $605,000.00 | $582,000.00 | $569,000.00 | $2.43M | $582,000.00 |
| Other Income (Expense) | -$12.95M | $13.58M | -$13.68M | $218.53M | -$24.11M |
| Gain on Sale of Security | -$13.23M | $9.81M | $6.59M | $21.31M | $18.25M |
| Special Income (Charges) | -$892,000.00 | -$2.50M | -$23.05M | $172.11M | -$48.02M |
| -Less:Restructuring and Mergern & Acquisition | $892,000.00 | $2.50M | -$168,000.00 | -$6.13M | -$28.26M |
| -Less:Write Off | $0.00 | $0.00 | $23.21M | $76.28M | $76.28M |
| Other Non-Operating Income (Expenses) | $1.17M | $6.28M | $2.77M | $25.11M | $5.66M |
| Pretax Profit | -$688.85M | $751.51M | $343.60M | $1.66B | $389.94M |
| Tax | $95.96M | $165.91M | $40.27M | $377.80M | $90.66M |
| Net Profit | -$784.80M | $585.61M | $303.33M | $1.29B | $299.28M |
| Profit from Continuing Operations | -$784.80M | $585.61M | $303.33M | $1.29B | $299.28M |
| Net Income to Parent Company | -$784.80M | $585.61M | $303.33M | $1.29B | $299.28M |
| Net Income to Common Stockholders | -$784.80M | $585.61M | $303.33M | $1.29B | $299.28M |
| Basic EPS | -$3.86 | $2.92 | $1.52 | $6.59 | $1.52 |
| Diluted EPS | -$3.86 | $2.81 | $1.47 | $6.41 | $1.46 |
| -Less:Other Special Charges | – | – | – | -$242.25M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $7.29B | $7.87B | $7.34B | $6.96B | $6.96B |
| Total Current Assets | $5.52B | $6.03B | $5.48B | $5.02B | $5.02B |
| Cash and Cash Equivalents & Short-Term Investments | $3.85B | $4.54B | $4.02B | $3.58B | $3.58B |
| -Cash and Cash Equivalents | $3.28B | $3.98B | $3.46B | $3.10B | $3.10B |
| -Short Term Investments | $578.69M | $553.37M | $554.71M | $482.79M | $482.79M |
| Receivables | $1.24B | $1.13B | $1.05B | $1.02B | $1.02B |
| -Accounts Receivable | $1.24B | $1.13B | $1.05B | $1.02B | $1.02B |
| Inventory | $134.25M | $112.54M | $115.62M | $101.06M | $101.06M |
| Other Current Assets | $295.52M | $253.09M | $301.31M | $317.83M | $317.83M |
| Total Non-Current Assets | $1.77B | $1.85B | $1.85B | $1.93B | $1.93B |
| Net PPE | $725.79M | $735.03M | $746.84M | $758.41M | $758.41M |
| -Gross PPE | $1.14B | $1.14B | $1.14B | $1.13B | $1.13B |
| -Accumulated Depreciation | -$414.71M | -$403.91M | -$389.00M | -$375.07M | -$375.07M |
| Investments and Advances | $91.16M | $104.39M | $54.58M | $47.99M | $47.99M |
| -Long Term Equity Investment | $91.16M | $104.39M | $54.58M | $47.99M | $47.99M |
| Goodwill and Other Intangible Assets | $236.23M | $236.20M | $243.16M | $250.13M | $250.13M |
| -Goodwill | $133.00M | $133.00M | $133.00M | $133.00M | $133.00M |
| -Other Intangible Assets | $103.23M | $103.20M | $110.16M | $117.13M | $117.13M |
| Non-Current Deferred Assets | $281.69M | $336.86M | $452.52M | $515.29M | $515.29M |
| Other Non-Current Assets | $431.02M | $433.60M | $357.75M | $362.25M | $362.25M |
| Total Liabilities | $1.64B | $1.53B | $1.72B | $1.79B | $1.79B |
| Total Current Liabilities | $1.44B | $1.31B | $1.49B | $1.52B | $1.52B |
| Payables | $238.25M | $252.64M | $234.56M | $214.69M | $214.69M |
| -Accounts Payable | $235.37M | $250.40M | $228.62M | $209.94M | $209.94M |
| -Total Tax Payable | $2.88M | $2.24M | $5.93M | $4.76M | $4.76M |
| Current Accrued Expenses | $267.21M | $267.51M | $279.92M | $287.86M | $287.86M |
| Short-Term Debt and Capital Lease Obligation | $9.78M | $9.85M | $10.02M | $10.21M | $10.21M |
| -Current Capital Lease Obligation | $9.78M | $9.85M | $10.02M | $10.21M | $10.21M |
| Current Provisions | $623.94M | $526.44M | $722.41M | $642.47M | $642.47M |
| Other Current Liabilities | $107.65M | $107.35M | $117.83M | $131.87M | $131.87M |
| Total Non-Current Liabilities | $206.50M | $216.12M | $226.62M | $275.33M | $275.33M |
| Long Term Debt and Capital Lease Obligation | $27.63M | $28.42M | $29.41M | $30.20M | $30.20M |
| -Long Term Capital Lease Obligation | $27.63M | $28.42M | $29.41M | $30.20M | $30.20M |
| Other Non-Current Liabilities | $178.87M | $187.70M | $197.20M | $245.13M | $245.13M |
| Total Equity | $5.64B | $6.34B | $5.62B | $5.17B | $5.17B |
| Stockholders' Equity | $5.64B | $6.34B | $5.62B | $5.17B | $5.17B |
| Capital Stock | $204,000.00 | $201,000.00 | $200,000.00 | $198,000.00 | $198,000.00 |
| -Common Stock | $204,000.00 | $201,000.00 | $200,000.00 | $198,000.00 | $198,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $5.31B | $5.22B | $5.08B | $4.93B | $4.93B |
| Retained Earnings | $317.90M | $1.10B | $517.10M | $213.77M | $213.77M |
| Gains/Losses Not Affecting Retained Earnings | $13.46M | $19.72M | $22.31M | $25.46M | $25.46M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$675.32M | $507.66M | $369.35M | $1.41B | $543.30M |
| Net cash flow from continuing operations | -$675.32M | $507.66M | $369.35M | $1.41B | $543.30M |
| Net Income from Continuing Operations | -$784.80M | $585.61M | $303.33M | $1.29B | $299.28M |
| Gain/Loss from Continuing Operations | $13.23M | – | – | -$21.31M | -$18.25M |
| Depreciation & Depletion & Amortization | $24.18M | $26.48M | $23.80M | $93.29M | $23.98M |
| Deferred Tax | $92.73M | $115.62M | $63.42M | $247.69M | $13.50M |
| Other Non-Cash Items | $9.60M | $4.11M | $12.60M | $8.73M | -$16.85M |
| Change in Working Capital | -$100.04M | -$281.61M | -$91.34M | -$527.16M | $103.20M |
| -Change in Receivables | -$111.87M | -$73.80M | -$27.03M | -$170.77M | -$128.50M |
| -Change in Inventory | -$21.67M | -$11.88M | -$12.23M | -$58.51M | -$4.86M |
| -Change in Prepaid Assets | -$80.85M | -$14.04M | $9.19M | -$156.24M | $65.04M |
| -Change in Payables and Accrued Expense | $114.35M | -$181.89M | -$61.28M | -$141.64M | $171.52M |
| Net cash flow from investing | -$44.34M | -$51.79M | -$88.20M | -$102.61M | -$37.42M |
| Net Cash Flow from Continuing Investing Activities | -$44.34M | -$51.79M | -$88.20M | -$102.61M | -$37.42M |
| Capital Expenditure | -$15.63M | -$12.41M | -$10.20M | -$58.87M | -$21.88M |
| Net Intangibles Purchase and Sale | $0.00 | $0.00 | -$5.00M | -$25.00M | $0.00 |
| Net Investment Purchase and Sale | -$28.70M | -$39.38M | -$73.00M | -$18.74M | -$15.54M |
| Financing Cash Flow | $13.94M | $65.46M | $84.82M | $101.04M | $137.74M |
| Net Cash Flow from Continuing Financing Activities | $13.94M | $65.46M | $84.82M | $101.04M | $137.74M |
| Net Issuance Payments Of Debt | -$1.15M | -$1.16M | -$1.18M | -$4.54M | -$1.16M |
| Proceeds from Stock Option Exercised | $122.30M | $75.15M | $97.93M | $221.76M | $160.21M |
| Net Other Financing Charges | -$107.22M | -$8.53M | -$11.92M | -$116.18M | -$21.31M |
| Ending Cash Balance | $3.28B | $3.98B | $3.46B | $3.10B | $3.10B |
| Net Change in Cash | -$705.72M | $521.33M | $365.97M | $1.41B | $643.62M |
| Beginning Cash Balance | $3.98B | $3.46B | $3.10B | $1.69B | $2.46B |
| Effect of Exchange Rate Changes | -$831,000.00 | -$84,000.00 | -$2.69M | -$1.71M | -$801,000.00 |
| Free Cash Flow | -$690.95M | $495.25M | $354.15M | $1.33B | $521.42M |
| Net Common Stock Issuance | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on INCY.
Sign in to join the discussion.